References
- RoweWJThe Apollo 15 space syndromeCirculation1998971191209443446
- WatenpaughDEBuckeyJCLaneLDEffects of spaceflight on human calf hemodynamicsJ Appl Physiol2001901552155811247959
- RoweWJInterplanetary travel and permanent injury to normal heartActa Astronaut19974071971072211543600
- RoweWJMoon dust may simulate vascular hazards of urban pollutionJBIS200760133136
- HigashiYSasakiSNakagawaKMatsuuraHOshimaTChayamaKEndothelial function and oxidative stress in renovascular hypertensionN Engl J Med20023461954196212075056
- LinKFChaoJChaoLHuman atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive ratsHypertension199526Part 18478537490138
- OhiSDeveloping protocols for recombinant adeno-associated virus-mediated gene therapy in spaceJ Gravit Physiol200076768
- AmidonGLDeBrincatGANajibNEffects of gravity on gastric emptying, intestinal transit, and drug absorptionJ Clin Pharmacol1991319689731761729
- DuJBayuseTMShahVPutchaLStability of pharmaceuticals during space flight [abstract]AAPS Pharm Sci2002T3153
- GraebeASchuckELLensingPPutchaLDerendorfHPhysiolgical, pharmacokinetic, and pharmacodynamic changes in spaceJ Clin Pharmacol20044483785315286087
- WadeCEMorey-HoltonEAlteration of renal function of rats following spaceflightAm J Physiol1998275R1058R10659756534
- Fritsch-YelleJMCharlesJBJonesMMWoodMLMicrogravity decreases heart rate and arterial pressure in humansJ Appl Physiol1996809109148964756
- ShiraishiMKamoTKamegaiMPeriodic structures and diurnal variation in blood pressure and heart rate in relation to microgravity on space station MIRBiomed Pharmacother200458S31S3415754836
- MatsukawaTManoTAtrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humansAm J Physiol19962712 Pt 2R464R4718770149
- CostaDMGonzalez BoscLVMajowiczMPVidalNABalaszczukAMArranzCTAtrial natriuretipeptide modifies arterial blood pressure through nitric oxide pathway in ratsHypertension2000351119112310818074
- WongNLMHuDCKWongEFCEffect of dietary magnesium on atrial natriuretic peptide releaseAm J Physiol19912615 Pt 2H1353H3571835306
- Leach HuntoonCSGrigorievAINatochinYVAmerican Astronaut SocietyFluid and Electrolyte Regulation in Spaceflight. (Science and Technology Series 94)San Diego, CAUnivelt1998
- AtkovOYBednenkoVSHypokinesia and Weightlessness: Clinical and physiologic aspectsMadison, WIInternational Universities Press1992167
- NeuhoferWPittrowDRole of endothelin and endothelin receptor antagonists in renal diseaseEur J Clin Invest200636788816919017
- LiaoTDYangXPLiuYHRole of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertensionHypertension20085225626318541733
- DhaunNGoddardJWebbDJThe endothelin system and its antagonism in chronic kidney diseaseJ Am Soc Nephrol20061794395516540557
- PedrinelliRGiampietroOCarmassiFMicroalbuminuria and endothelial dysfunction in essential hypertensionLancet199434414187912295
- Mena-MartínFJMartín-EscuderoJCSimal-BlancoFCarretero-AresJLArzúa-MouronteDCastrodeza SanzJJHortega Study Investigators. Influence of sympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretionJ Clin Hypertens (Greenwich)2006861962416957423
- FutrakulNSridamaVFutrakulPMicroalbuminuria – A biomarker of renal microvascular diseaseRen Fail20093114014319212911
- WangTJEvansJCMeigsJBLow-grade albuminuria and the risks of hypertension and blood pressure progressionCirculation20051111370137615738353
- RadomskiMWPalmerRMJMoncadaSEndogenous nitric oxide inhibits human platelet adhesion to vascular endotheliumLancet198728567105710582889967
- RoweWJThe case for a subcutaneous magnesium product and delivery device for space missionsJ Am Coll Nutr200423525S528S15466957
- HaraAWadaTFuruichiKBlockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritisKidney Int2006691986199516641924
- MasudaYShimizuAMoriTVascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritisAm J Pathol200115959960811485918
- DavidsonMBHixJKVidtDGBrotmanDJAssociation of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rateArch Intern Med200616684685216636209
- PhilpottDEPopovaIAKatoKStevensonJMiquelJSappWMorphological and biochemical examination of Cosmos 1887 rat heart tissue: Part I – UltrastructureFASEB J1990473782295379
- SteinTPSpace flight and oxidative stressNutrition20021886787112361781
- GarciaLADejongSCMartinSMSmithRSBuettnerGRKerberREMagnesium reduces free radicals in an in vivo coronary occlusion reperfusion modelJ Am Coll Cardiol1998325365399708488
- GracianoMLCavaglieri RdeCDellêHIntrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesisJ Am Soc Nephrol2004151805181515213268
- CampbellRCThe renin-angiotensin system: a 21st century perspectiveJ Am Soc Nephrol2004151963196415213288
- GrassiGAssessment of sympathetic cardiovascular drive in human hypertensionHypertension20095469070619720958
- ChristensenNJDrummerCNorskPRenal and sympathoadrenal responses in spaceAm J Kidney Dis20013867968311532706
- BrennerBMBallermanBJGunningMEZeidelMLDiverse biological actions of atrial natriuretic peptidePhysiol Rev1990706656992141944
- SeeligMCardiovascular consequences of magnesium deficiency and loss: pathogenesis prevalence and manifestations-magnesium and chloride loss in refractory potassium repletionAm J Cardiol1989634G21G
- SontiaBMontezanoACIParaviciniTTabetFTouyzRMDown-regulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesiumHypertension20085191592118268139
- RemuzziGCattaneoDPericoNThe aggravating mechanisms of aldosterone on kidney fibrosisJ Am Soc Nephrol2008191459146218550649
- ClarkBAElahiDEpsteinFHThe influence of gender, age, and the menstrual cycle on plasma natriuretic peptideJ Clin Endocrin Metab199070349352
- RosslerANoskovVLaszloZPolyakowVVHinghoffer-SzalkayHGPermanent depression of plasma cGMP during long-term space flightPhysiol Res200150839011300230
- Malamitsi-PuchnerATziotisJTsonouAProtonotariouESarandakouACreatsasGChanges in serum levels of vascular endothelial growth factor in males and females throughout lifeJ Soc Gynecol Investig20007309312
- VaziriNDRodriguez-IturbeBMechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertensionNat Clin Pract Nephrol2006258259317003837
- RoweWJExtraordinary hypertension after a lunar missionAm J Med2009122e119854309
- DzieciuchowiczLChecinskiPKraussHHeparin reduces oxidative stress in the postoperative periodMed Sci Monit20028CR657CR66012218949
- MaierJAMMalpuech-BrugèreCZimowskaWRayssiguierYMazurALow magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosisBiochim Biophys Acta20041689132115158909
- WeglickiWBPhillipsTMFreedmanAMCassidyMMDickensBFMagnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelinMol Cell Biochem19921101691731584207
- LinKFChaoLChaoJProlonged reduction of high blood pressure with human nitric oxide synthase gene deliveryHypertension199730Part 13073139314409
- SchillingerKJTsaiSYTaffetGERegulatable atrial natriuretic peptide gene therapy for hypertensionProc Natl Acad Sci U S A2005102137891379416162668
- McCarthyHOCoulterJARobsonTHirstDGGene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditionsJ Pharm Pharmacol200860999101718644193
- KohnDBCandottiFGene therapy fulfilling its promiseN Engl J Med200936051852119179320